Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Asahi Kasei Obtains Rights To Reveal DX From Medtronic Japan And Enters Medical Device Business

This article was originally published in PharmAsia News

Executive Summary

Asahi Kasei announced July 15 that the company will enter the medical device business by obtaining exclusive rights to market insertable cardiac monitor Reveal DX from Medtronic Japan. Asahi Kasei plans to launch the device to the market next spring and estimate the sales to reach ¥7 billion by 2015. Developed by Medtronic, Medtronic Japan received approval for Reveal DX in July. (Click here for more - Japanese language

Table

View full table

Tags:
Latest Headlines

X4 Gets First Approval In Ultra-Rare Disorder, Needs Time To Build A Market

Ono Buys Deciphera, Gaining A Commercial Cancer Drug And Infrastructure

AstraZeneca And Daiichi Get Low

Pipeline Watch: Eighteen Approvals And Six Phase III Trial Updates

See All
UsernamePublicRestriction

Register

SC069030

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By